New Q&As on Chapter 4 and 5 of the EU-GDP Guidelines
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
On the GDP Association Website a section was set up a while ago dealing with frequently asked questions (FAQs). Now a set of new FAQs has been published on Chapter 4 (Documentation) and Chapter 5 (Operations).
For example, the following questions are discussed:
- Who authors documents? Who needs to approve them?
- In which language should documents be written?
- Is it allowed to print procedures from an electronic system?
- How can I check if a supplier has an appropriate legal authorisation?
- Besides temperature, are there other environmental factors which might harm medicinal products?
- Why do I need to qualify customers?
Answers to these and other questions are provided in the new FAQs on GDP.
Related GMP News
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting
18.06.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 4
18.06.2026GDP Non-Compliance Report: Missed CAPA Timelines lead to Refusal of GDP Certificate
17.06.2026European GDP Association Developments January through April 2026
12.05.2026How Are Service Providers Qualified in a GDP Environment?
12.05.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 3


